• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

维生素 D 缺乏、胰岛素抵抗和抗苗勒管激素水平:多囊卵巢综合征表现中的三重奏。

Vitamin D deficiency, insulin resistance, and antimüllerian hormone level: a tale of trio in the expression of polycystic ovary syndrome.

机构信息

Clinicogenomics Lab, Sir Surendranath Banerjea Advanced Research Centre, Department of Physiology, Surendranath College, University of Calcutta, Kolkata, West Bengal, India.

Department of Gynaecology and Obstetrics, Medical College, Kolkata, West Bengal, India.

出版信息

F S Sci. 2024 Aug;5(3):252-264. doi: 10.1016/j.xfss.2024.06.002. Epub 2024 Jun 12.

DOI:10.1016/j.xfss.2024.06.002
PMID:38876205
Abstract

OBJECTIVE

To study the association between altered vitamin D profiles and different indices as well as clinical features of polycystic ovary syndrome (PCOS), including antimüllerian hormone (AMH) levels, phenotypes (A [hyperandrogenism {HA} + ovulatory dysfunction {OD} + polycystic ovarian morphology {PCOM}], B [HA + OD], C [HA + PCOM], and D [OD + PCOM]), insulin resistance, oligomenorrhea, hyperandrogenism, obesity indices, and stress biomarkers in the ethnic population of West Bengal.

DESIGN

Case-control observational study.

SETTING

Outpatient department of gynecology and obstetrics and environing.

PARTICIPANTS (PATIENTS AND CONTROL): Sample size: case group (PCOS, n = 160), age: 16-38 years, and their gender, age, as well as ethnicity-matched healthy control (n = 160).

INTERVENTION(S): In this observational study, a structured questionnaire for menstrual status and to determine the scores of cutaneous manifestations, a bioelectrical impedance analyzer for measurement of anthropometric indices, relevant biochemical assessments (vitamin D, AMH, insulin, glucose, and other associated hormonal profiles), statistical software for the social sciences, and Microsoft Office Excel were used to evaluate as well as analyze different indices.

MAIN OUTCOME MEASURE(S): Study of the association of vitamin D deficiency with differential manifestations of PCOS such as phenotypes of the syndrome, altered AMH levels, and risk of insulin resistance. An attempt has been made to determine the cutoff value of AMH of the patients with PCOS belonging to the ethnic population of West Bengal using receiver operating characteristic (ROC).

RESULT(S): Vitamin D deficiency was found to be directly correlated with AMH level in PCOS phenotype A (67%), oligomenorrhea, and PCOM, along with a substantial agonistic relationship with insulin resistance in the PCOS population under study. In the PCOS phenotype B, the AMH level was highest, with a cutoff value of 5.27 ng/mL (asymptotic sig. = 0.000, 95% confidence interval: 8.37-9.95, derived by ROC analysis, with area under the ROC curve- area under the curve value = 0.949, sensitivity=0.882, and specificity = 0.880). Oligomenorrhic women with PCOS possess significantly higher values of AMH levels (8.70 ± 3.66 > 3.09 ± 1.86 ng/mL) level than the regular menstrual rhythm within the same group. Patients with PCOS had significantly less skeletal muscle mass and greater subcutaneous fat content than the control group.

CONCLUSION(S): 25-hydroxy-vitamin D might be intermeshed with the underlying pathophysiology and severity of PCOS, as well as associated metabolic disorders like insulin resistance. The AMH level is finely tuned by most of the plausible effectors of PCOS and contends to be a promising biomarker for the diagnosis as well as prognosis of PCOS.

摘要

目的

研究维生素 D 谱的改变与多囊卵巢综合征(PCOS)的不同指标和临床特征之间的关联,包括抗缪勒管激素(AMH)水平、表型(A[高雄激素血症{HA}+排卵功能障碍{OD}+多囊卵巢形态{PCOM}]、B[HA+OD]、C[HA+PCOM]和 D[OD+PCOM])、胰岛素抵抗、稀发排卵、高雄激素血症、肥胖指数和应激生物标志物之间的关系,研究对象为西孟加拉邦的族群。

设计

病例对照观察性研究。

地点

妇产科门诊及周边地区。

参与者(患者和对照组):样本量:病例组(PCOS,n=160),年龄 16-38 岁,以及他们的性别、年龄和种族匹配的健康对照组(n=160)。

干预措施

在这项观察性研究中,使用了一个用于月经状况和确定皮肤表现评分的结构化问卷、一个用于测量人体测量指数的生物电阻抗分析仪、相关的生化评估(维生素 D、AMH、胰岛素、葡萄糖和其他相关激素谱)、用于社会科学的统计软件和 Microsoft Office Excel 来评估和分析不同的指标。

主要观察结果

研究维生素 D 缺乏与 PCOS 不同表现(如综合征表型、AMH 水平改变和胰岛素抵抗风险)之间的关联。尝试使用受试者工作特征(ROC)分析确定来自西孟加拉邦族群的 PCOS 患者的 AMH 截断值。

结果

在 PCOS 表型 A(67%)、稀发排卵和 PCOM 中,维生素 D 缺乏与 AMH 水平直接相关,并与研究人群中的胰岛素抵抗呈显著的协同关系。在 PCOS 表型 B 中,AMH 水平最高,截断值为 5.27ng/mL(渐近显著=0.000,95%置信区间:8.37-9.95,由 ROC 分析得出,ROC 曲线下面积-曲线下面积值=0.949,敏感性=0.882,特异性=0.880)。患有 PCOS 的稀发排卵妇女的 AMH 水平显著高于同组的正常月经节律(8.70±3.66>3.09±1.86ng/mL)。与对照组相比,PCOS 患者的骨骼肌质量明显减少,皮下脂肪含量明显增加。

结论

25-羟维生素 D 可能与 PCOS 的潜在病理生理学和严重程度以及胰岛素抵抗等相关代谢紊乱有关。AMH 水平受 PCOS 的大多数可能效应因子的精细调节,并被认为是 PCOS 诊断和预后的有前途的生物标志物。

相似文献

1
Vitamin D deficiency, insulin resistance, and antimüllerian hormone level: a tale of trio in the expression of polycystic ovary syndrome.维生素 D 缺乏、胰岛素抵抗和抗苗勒管激素水平:多囊卵巢综合征表现中的三重奏。
F S Sci. 2024 Aug;5(3):252-264. doi: 10.1016/j.xfss.2024.06.002. Epub 2024 Jun 12.
2
Antimüllerian hormone to determine polycystic ovarian morphology.抗苗勒管激素用于判断多囊卵巢形态。
Fertil Steril. 2021 Oct;116(4):1149-1157. doi: 10.1016/j.fertnstert.2021.05.094.
3
Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.多囊卵巢形态学与多囊卵巢综合征的诊断:应用聚类分析重新定义卵泡计数和血清抗苗勒管激素的临界值。
Hum Reprod. 2017 Aug 1;32(8):1723-1731. doi: 10.1093/humrep/dex226.
4
Using cluster analysis to identify a homogeneous subpopulation of women with polycystic ovarian morphology in a population of non-hyperandrogenic women with regular menstrual cycles.在月经周期规律的非高雄激素血症女性群体中,使用聚类分析来识别具有多囊卵巢形态的同质亚组女性。
Hum Reprod. 2014 Nov;29(11):2536-43. doi: 10.1093/humrep/deu242. Epub 2014 Sep 29.
5
Use of the serum anti-Müllerian hormone assay as a surrogate for polycystic ovarian morphology: impact on diagnosis and phenotypic classification of polycystic ovary syndrome.将血清抗苗勒管激素检测作为多囊卵巢形态的替代指标:对多囊卵巢综合征的诊断和表型分类的影响。
Hum Reprod. 2017 Aug 1;32(8):1716-1722. doi: 10.1093/humrep/dex239.
6
Differentiation between polycystic ovary syndrome and polycystic ovarian morphology by means of an anti-Müllerian hormone cutoff value.通过抗苗勒管激素临界值鉴别多囊卵巢综合征和多囊卵巢形态。
Korean J Intern Med. 2017 Jul;32(4):690-698. doi: 10.3904/kjim.2016.038. Epub 2016 Nov 30.
7
Comparison of Anti-müllerian Hormone (AMH) and Hormonal Assays for Phenotypic Classification of Polycystic Ovary Syndrome.抗缪勒管激素(AMH)与激素检测在多囊卵巢综合征表型分类中的比较。
Ginekol Pol. 2020;91(11):661-667. doi: 10.5603/GP.a2020.0122.
8
Anti-müllerian hormone as a diagnostic biomarker for polycystic ovary syndrome and polycystic ovarian morphology: a systematic review and meta-analysis.抗缪勒管激素作为多囊卵巢综合征和多囊卵巢形态的诊断生物标志物:系统评价和荟萃分析。
Fertil Steril. 2024 Oct;122(4):727-739. doi: 10.1016/j.fertnstert.2024.05.163. Epub 2024 Jun 27.
9
Phenotypic variation in anti-Mullerian hormone (AMH) production per follicle in women with polycystic ovary syndrome (PCOS) and isolated polycystic ovarian morphology (PCOM): an observational cross-sectional study.多囊卵巢综合征(PCOS)和单纯性多囊卵巢形态(PCOM)女性卵泡抗苗勒管激素(AMH)分泌的表型变异:一项观察性横断面研究。
Gynecol Endocrinol. 2017 Oct;33(10):801-806. doi: 10.1080/09513590.2017.1320377. Epub 2017 Apr 28.
10
Serum anti-Mullerian hormone levels in the main phenotypes of polycystic ovary syndrome.多囊卵巢综合征主要表型的血清抗苗勒管激素水平。
Eur J Obstet Gynecol Reprod Biol. 2013 Sep;170(1):157-61. doi: 10.1016/j.ejogrb.2013.05.019. Epub 2013 Jun 24.

引用本文的文献

1
Supervised model based polycystic ovarian syndrome detection in relation to vitamin d deficiency by exploring different feature selection techniques.通过探索不同的特征选择技术,基于监督模型检测多囊卵巢综合征与维生素D缺乏的关系。
Sci Rep. 2025 Aug 26;15(1):31481. doi: 10.1038/s41598-025-14728-z.
2
The Molecular Basis of Polycystic Ovary Syndrome and Its Cardiometabolic Correlates: Exploring the Intersection and Its Clinical Implications-A Narrative Review.多囊卵巢综合征的分子基础及其心脏代谢相关性:探索交叉点及其临床意义——一篇叙述性综述
Biomedicines. 2025 Mar 13;13(3):709. doi: 10.3390/biomedicines13030709.
3
Association of TCF7L2 genetic variants rs12255372 and rs7903146 with the polycystic ovary syndrome risk: systemic review and meta-analysis.
TCF7L2基因变异rs12255372和rs7903146与多囊卵巢综合征风险的关联:系统评价与荟萃分析。
J Ovarian Res. 2025 Jan 6;18(1):2. doi: 10.1186/s13048-024-01585-z.